Buy This, Not That: Are AI ETFs Worth Your Time?
Readers have been asking about AI ETFs. But there’s something you need to understand about these five funds (and AI ETFs in general)…
Monday Takeaways: Markets Are Getting Political
We’ve got a big political week ahead. From the 2024 Democratic National Convention to fresh FOMC meeting notes, a big speech from Jerome Powell and more…
Buy This, Not That: This Recession-Proof Favorite Might Be in Trouble
When people start to tighten their belts… their spending shifts from dining out to getting takeout. Let’s look at some of the biggest cooks in the fast-food kitchen.
Monday Takeaways: Misplaced Optimism Could Be Costly
The markets rallied after last week’s big dust-up… but we’re not out of the woods yet. Here’s why.
Dealmaker’s Diary: The Stock Financing Our Energy Future
You don’t have to believe in climate change to like this company…
Buy This, Not That: When to Load Back Up on the Magnificent 7
The Magnificent Seven have sold off hard. In this special edition of Buy This, Not That, Shah shows us where the best buying opportunities are.
Monday Takeaways: Sentiment Has Turned… Get Ready to Buy
The Fed’s promise of a rate cut did nothing to calm nerves after a poor job report. Here’s what’s coming…
Buy This, Not That: Looking for Fertile Profits With These 6 Ag Stocks
The agriculture sector grows and wilts by the changing of the seasons… the weather… and supply/demand. But what about the companies that support the ag business worldwide?
Monday Takeaways: The Number to Watch This Week
Was last week’s late stage rally a sign of things to come… these crucial numbers have the answer.
Buy This, Not That: A Big Dose of 5 Big Pharma Stocks
Which of these five drugmakers stocks hands out a prescription for portfolio health?